Couldn't agree more
@Un1qu3Nam3 with everything.
It looks to me, very much a concerted shake down & I think your post just upset the puppeteer.
There are some hedges currently organising dedicated biotech funds...Perhaps a certain fund has an eye on PTX & doesn't want a placement at 40c when they can have it for 20c?
Only way is up for PTX really, like Steven said it will be end of 2022 before anything even has the chance to disappoint by which stage a whole lot of good water will have flown under the bridge...Stealth Cell therapy program is not a maybe good...It's a definite good & the data is ballisimo as Steven put it..As soon as patents are granted it's off to the races.
Whilst it's not expected, I totally agree that if Steven & the BOD are so excited for the future...Perhaps buying on market now would be good stewardship...Fantastic stewardship actually...I believe the stat's will say that when a director buys on market it usually means great things to come about 78% of the time...That's good statistics.
The SAB and whole PTX team are guns...I actually just rang Professor Miles Prince clinic about a referral for Dad in regards to blood clots...There is literally no one better than Professor Miles Prince who will take a look & triage his case accordingly I'm told so that Dad is seeing the right person in the right amount of time by his team.
